Order Article Reprints

Gunasekaran P, Shin SC, Hwang YS, Lee J, La YK, Yim MS, Kim HN, Kim TW, Yang E, Lee SJ, et al. N-Degron-Based PROTAC Targeting PLK1: A Potential Therapeutic Strategy for Cervical Cancer. Pharmaceutics. 2025; 17(8):1027. https://doi.org/10.3390/pharmaceutics17081027

Gunasekaran, Pethaiah, Sang Chul Shin, Yeon Sil Hwang, Jihyeon Lee, Yeo Kyung La, Min Su Yim, Hak Nam Kim, Tae Wan Kim, Eunjung Yang, Soo Jae Lee, and et al. 2025. "N-Degron-Based PROTAC Targeting PLK1: A Potential Therapeutic Strategy for Cervical Cancer" Pharmaceutics 17, no. 8: 1027. https://doi.org/10.3390/pharmaceutics17081027

Gunasekaran, P., Shin, S. C., Hwang, Y. S., Lee, J., La, Y. K., Yim, M. S., Kim, H. N., Kim, T. W., Yang, E., Lee, S. J., Yoon, J. M., Kim, E. E., Jeon, S., Ryu, E. K., & Bang, J. K. (2025). N-Degron-Based PROTAC Targeting PLK1: A Potential Therapeutic Strategy for Cervical Cancer. Pharmaceutics, 17(8), 1027. https://doi.org/10.3390/pharmaceutics17081027